FDx Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,621
Closed -$710K 231
2024
Q1
$710K Sell
2,621
-1,018
-28% -$243K 0.11% 165
2023
Q4
$860K Sell
3,639
-452
-11% -$88.9K 0.07% 290
2023
Q3
$802K Sell
4,091
-4,829
-54% -$991K 0.07% 260
2023
Q2
$1.88M Sell
8,920
-611
-6% -$122K 0.1% 199
2023
Q1
$2.08M Hold
9,531
0.09% 190
2022
Q4
$2.08M Sell
9,531
-1,934
-17% -$422K 0.09% 190
2022
Q3
$2.26M Sell
11,465
-1,793
-14% -$387K 0.1% 172
2022
Q2
$2.84M Buy
13,258
+252
+2% +$61.6K 0.11% 171
2022
Q1
$3.69M Buy
13,006
+355
+3% +$109K 0.13% 137
2021
Q4
$4.77M Buy
12,651
+892
+8% +$347K 0.13% 131
2021
Q3
$4.85M Buy
11,759
+950
+9% +$395K 0.15% 115
2021
Q2
$4M Buy
10,809
+1,107
+11% +$370K 0.13% 132
2021
Q1
$2.81M Buy
9,702
+4,722
+95% +$1.31M 0.11% 147
2020
Q4
$1.24M Buy
4,980
+1,034
+26% +$246K 0.05% 229
2020
Q3
$894K Sell
3,946
-1,637
-29% -$340K 0.04% 254
2020
Q2
$973K Buy
5,583
+2,580
+86% +$412K 0.05% 233
2020
Q1
$379K Sell
3,003
-763
-20% -$114K 0.02% 344
2019
Q4
$575K Sell
3,766
-20
-0.5% -$2.77K 0.03% 322
2019
Q3
$501K Buy
3,786
+334
+10% +$44.8K 0.03% 341
2019
Q2
$490K Sell
3,452
-28
-0.8% -$3.8K 0.02% 493
2019
Q1
$505K Sell
3,480
-587
-14% -$77.1K 0.02% 463
2018
Q4
$460K Sell
4,067
-1,130
-22% -$141K 0.04% 320
2018
Q3
$699K Buy
5,197
+756
+17% +$93.3K 0.03% 423
2018
Q2
$499K Sell
4,441
-62
-1% -$6.7K 0.02% 547
2018
Q1
$481K Sell
4,503
-1,055
-19% -$114K 0.01% 784
2017
Q4
$608K Buy
5,558
+485
+10% +$52.8K 0.02% 718
2017
Q3
$548K Buy
+5,073
New +$521K 0.02% 763
2015
Q1
Sell
-4,326
Closed -$275K 1879
2014
Q4
$275K Buy
4,326
+92
+2% +$5.77K 0.02% 751
2014
Q3
$253K Buy
4,234
+79
+2% +$4.52K 0.02% 843
2014
Q2
$222K Buy
+4,155
New +$228K 0.01% 906

Other funds holding CRL